German Medicines Act (AMG) / German Medical Devices Act (MPG)
The AMG / MPG working group is the initial point of contact for inquiries from the pharmaceutical industry and medical technology firms, and coordinates the exchange with the trials and studies groups and lighthouse groups in the BZKF. The core task of the workgroup is to collect and prioritize the innovative research approaches developed in the trials and studies groups and lighthouse groups, in order to present them to the pharmaceutical industry further along their course of development. The trials and studies groups thus get the opportunity to conduct phase I clinical trials, among other things, together with the pharmaceutical industry. In this way, the WG ensures that industry and the research groups of the BZKF collaborate optimally.
Working Group Leader
Prof. Dr. Julia Mayerle, LMU Klinikum München